Safety, immunogenicity and clinical efficacy of an allergen vaccine (CYT005-AllQbG10) in subjects with seasonal rhinoconjunctivitis due to grass-pollen allergy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to evaluate whether the use of a specific immunomodulatory principle (QbG10) together with conventional grass pollen allergen leads to a more rapid and more pronounced decrease of sensitivity against pollen than with the grass pollen allergen alone
Epistemonikos ID: 0c2f478cb0e51ce3fe802f471cd9bed16ff4c6a5
First added on: May 04, 2024